Picture Berlin Partner Health Capital Computational Biology 2022 650x100px

Document › Details

Fluidigm Corporation. (8/28/17). "Press Release: Fluidigm to Participate in Two Upcoming Health Care Conferences in September". South San Francisco, CA.

	Region	New York, NY
	Country	United States (USA)
	Organisation	Fluidigm Corporation (Nasdaq: FLDM)
	Group	Fluidigm (Group)
	Organisation 2	Morgan Stanley & Co. LLC
	Group	Morgan Stanley (Group)
	Product	Morgan Stanley Global Healthcare Conference 2017 New York
	Product 2	Cantor Fitzgerald Healthcare Conference 2017 New York
	Index term	Fluidigm–Morgan Stanley: investor conference, 201709 supply service Fludigm presents at Morgan Stanley Global Healthcare Conference
	Index term 2	Fluidigm–Cantor Fitzgerald: investor conference, 201709 supply service Fluidigm presents at Cantor Fitzegerald Global Healthcare Conference in NY
	Person	Linthwaite, S. Christopher (Chris) (Fluidigm 201610– CEO joined 201608 as COO before Thermo Fisher + Life Technologies)
	Person 2	Jog, Vikram (Fluidigm 200802– CFO before XDx CFO + Applera)

Fluidigm Corporation (NASDAQ:FLDM) today announced that Chris Linthwaite, President and CEO, and Vikram Jog, Chief Financial Officer, will participate in two upcoming health care conferences in New York, NY.

Morgan Stanley 15th Annual Global Health Care Conference
Linthwaite will participate in a fireside chat presentation on Monday, September 11, at 4:50 pm ET at the Grand Hyatt New York.

Cantor Fitzgerald Healthcare Conference
Linthwaite will also present on Tuesday, September 26, at 4:00 pm ET at the InterContinental New York Barclay Hotel.

Live webcasts of the company's presentations and subsequent replays may be accessed at http://investors.fluidigm.com/events.cfm. The webcasts will be archived for 90 days following the live presentations.

About Fluidigm

Fluidigm (NASDAQ:FLDM) develops, manufactures, and markets life science analytical and preparatory systems for markets such as mass cytometry, high-throughput genomics, and single-cell genomics. We sell to leading academic institutions, clinical research laboratories, and pharmaceutical, biotechnology, and agricultural biotechnology companies worldwide. Our systems are based on proprietary microfluidics and multiparameter mass cytometry technology and are designed to significantly simplify experimental workflow, increase throughput, and reduce costs while providing excellent data quality. Fluidigm products are provided for Research Use Only. Not for use in diagnostic procedures.

Fluidigm and the Fluidigm logo are trademarks or registered trademarks of Fluidigm Corporation.

Contact:

Fluidigm Corporation
Ana Petrovic
Director, Corporate Development and Investor Relations
650.243.6628 (Office)
ana.petrovic@fluidigm.com

Record changed: 2017-08-29